ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, today announced that Richard Faleschini, President and Chief Executive Officer, is scheduled to present at the Needham & Company, LLC 10th Annual Growth Stock Conference on Tuesday, January 8, 2008 at 2:00 p.m. Eastern Time. The event is taking place at the New York Palace Hotel.
